BioNTech SE is 19.6x more valuable than DBV Technologies S.A. by market capitalization ($21.79 B vs $1.11 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | DBVT | BNTX |
|---|---|---|
| Market cap | $1.11 B | $21.79 B |
| US-listed rank | #2563 | #587 |
| Revenue (latest FY) | $5.64M | - |
| Net income (latest FY) | -$146.95M | - |
| Net margin | -2607.3% | - |
| SEC filings | 563 | 548 |
BioNTech SE is 19.6x more valuable than DBV Technologies S.A. by market capitalization ($21.79 B vs $1.11 B).
Full pages: DBV Technologies S.A. and BioNTech SE, or browse the full rankings.